| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 03/06/2024 | 20:11 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | AMEX:KNW | Know Labs Inc |
| 29/05/2024 | 22:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:KNW | Know Labs Inc |
| 16/05/2024 | 15:00 | Business Wire | Know Labs Appoints Chris Somogyi as President, International | AMEX:KNW | Know Labs Inc |
| 15/05/2024 | 22:15 | Business Wire | Know Labs, Inc. Reports Second Quarter FY 2024 Results | AMEX:KNW | Know Labs Inc |
| 09/05/2024 | 15:00 | Business Wire | Know Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual Meeting | AMEX:KNW | Know Labs Inc |
| 08/05/2024 | 15:00 | Business Wire | Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024 | AMEX:KNW | Know Labs Inc |
| 05/04/2024 | 15:00 | Business Wire | Know Labs to Present Clinical Research at the 2024 American Physiology Summit | AMEX:KNW | Know Labs Inc |
| 06/03/2024 | 22:15 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | AMEX:KNW | Know Labs Inc |
| 06/03/2024 | 22:10 | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:KNW | Know Labs Inc |
| 06/03/2024 | 15:00 | Business Wire | Know Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study | AMEX:KNW | Know Labs Inc |
| 29/02/2024 | 22:15 | Business Wire | Know Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development Initiatives | AMEX:KNW | Know Labs Inc |
| 27/02/2024 | 17:44 | Business Wire | Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor | AMEX:KNW | Know Labs Inc |
| 14/02/2024 | 22:17 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | AMEX:KNW | Know Labs Inc |
| 14/02/2024 | 22:15 | Business Wire | Know Labs, Inc. Reports First Quarter FY2024 Results | AMEX:KNW | Know Labs Inc |
| 07/02/2024 | 15:00 | Business Wire | Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024 | AMEX:KNW | Know Labs Inc |
| 23/01/2024 | 15:00 | Business Wire | Know Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) | AMEX:KNW | Know Labs Inc |
| 12/01/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | AMEX:KNW | Know Labs Inc |
| 05/01/2024 | 22:16 | Edgar (US Regulatory) | Form S-3/A - Registration statement under Securities Act of 1933: [Amend] | AMEX:KNW | Know Labs Inc |
| 22/12/2023 | 22:15 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of 1933 | AMEX:KNW | Know Labs Inc |
| 19/12/2023 | 22:15 | Business Wire | Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results | AMEX:KNW | Know Labs Inc |
| 19/12/2023 | 22:03 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | AMEX:KNW | Know Labs Inc |
| 19/12/2023 | 12:10 | IH Market News | Google $700M Antitrust Settlement, TSMC Chairman Retirement, Tesla Nevada Wage Hike, and More | AMEX:KNW | Know Labs Inc |
| 14/12/2023 | 15:00 | Business Wire | Know Labs Expands Medical and Scientific Advisory Board | AMEX:KNW | Know Labs Inc |
| 12/12/2023 | 22:04 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | AMEX:KNW | Know Labs Inc |
| 11/12/2023 | 15:00 | Business Wire | Know Labs, Inc. to Host Review of Fiscal Year 2023 Results on December 19, 2023 | AMEX:KNW | Know Labs Inc |
| 08/11/2023 | 15:00 | Business Wire | Know Labs Expands Board of Directors | AMEX:KNW | Know Labs Inc |
| 31/10/2023 | 14:00 | Business Wire | Know Labs Presents at Third Annual Bernstein CGM Disruptors Conference, Details Significant Progress During the Past Year | AMEX:KNW | Know Labs Inc |
| 18/10/2023 | 14:07 | Edgar (US Regulatory) | Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] | AMEX:KNW | Know Labs Inc |
| 27/09/2023 | 14:00 | Business Wire | Know Labs, Inc. Announces Pricing of $7 Million Public Offering of Common Stock | AMEX:KNW | Know Labs Inc |
| 25/09/2023 | 17:57 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] | AMEX:KNW | Know Labs Inc |